Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MR-Linac Technical Feasibility Protocol For Development of MR-guided Adaptive RadiationTherapy

NCT04351204 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT04351204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04351204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MR-Linac Technical Feasibility Protocol For Development of MR-guided Adaptive RadiationTherapy
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Unknown status
Start date
January 22, 2019
Completion date
July 1, 2026
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tumors at all sites which will receive radiotherapy